Literature DB >> 12510814

Hadju-Cheney syndrome: response to therapy with bisphosphonates in two patients.

W M Drake1, M P Hiorns, D L Kendler.   

Abstract

Hadju-Cheney syndrome is characterized by short stature, distinctive facies, and a slowly progressive skeletal dysplasia including acro-osteolysis. Autosomal dominant inheritance is typical, but the genetic defect and molecular pathogenesis of the syndrome are unknown. Osteoporosis with atraumatic fracture is a frequent finding, and previous studies have documented biochemical and morphometric evidence of high bone turnover. Here, we report the clinical details and response to therapy with bisphosphonates in two patients (mother and son) with Hadju-Cheney syndrome and postulate that osteoclast-mediated bone resorption is important in the generalized osteoporosis commonly associated with this condition.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12510814     DOI: 10.1359/jbmr.2003.18.1.131

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  9 in total

1.  Bone Structural Characteristics and Response to Bisphosphonate Treatment in Children With Hajdu-Cheney Syndrome.

Authors:  Sophia Sakka; Rachel I Gafni; Justin H Davies; Bart Clarke; Peter Tebben; Mark Samuels; Vrinda Saraff; Klaus Klaushofer; Nadja Fratzl-Zelman; Paul Roschger; Frank Rauch; Wolfgang Högler
Journal:  J Clin Endocrinol Metab       Date:  2017-11-01       Impact factor: 5.958

2.  Integrated anti-remodeling and anabolic therapy for the osteoporosis of Hajdu-Cheney syndrome.

Authors:  F E McKiernan
Journal:  Osteoporos Int       Date:  2006-11-14       Impact factor: 4.507

3.  Surgical challenges in the management of cervical kyphotic deformity in patients with severe osteoporosis: an illustrative case of a patient with Hajdu-Cheney syndrome.

Authors:  Tobias A Mattei; Azeem A Rehman; Ahmad Issawi; Daniel R Fassett
Journal:  Eur Spine J       Date:  2015-07-22       Impact factor: 3.134

4.  Scoliosis Correction in an Adolescent With Hajdu-Cheney Syndrome: A Case Report.

Authors:  Bhavuk Garg; Nishank Mehta
Journal:  HSS J       Date:  2022-03-11

Review 5.  The role of bisphosphonates in diseases of childhood.

Authors:  Tarak Srivastava; Uri S Alon
Journal:  Eur J Pediatr       Date:  2003-09-11       Impact factor: 3.183

6.  Effect of zoledronic acid on acro-osteolysis and osteoporosis in a patient with Hajdu-Cheney syndrome.

Authors:  Sena Hwang; Dong Yoeb Shin; Seong Hwan Moon; Eun Jig Lee; Sung-Kil Lim; Ok Hwa Kim; Yumie Rhee
Journal:  Yonsei Med J       Date:  2011-05       Impact factor: 2.759

Review 7.  Craniospinal Surgery in Hajdu-Cheney Syndrome: A Review of Case Reports.

Authors:  Cody J Falls; Paul S Page; James A Stadler
Journal:  Cureus       Date:  2021-12-18

Review 8.  Progress and Current Status in Hajdu-Cheney Syndrome with Focus on Novel Genetic Research.

Authors:  Natsuko Aida; Tatsukuni Ohno; Toshifumi Azuma
Journal:  Int J Mol Sci       Date:  2022-09-27       Impact factor: 6.208

Review 9.  Bisphosphonate therapy for spinal osteoporosis in Hajdu-Cheney syndrome - new data and literature review.

Authors:  James F H Pittaway; Christopher Harrison; Yumie Rhee; Muriel Holder-Espinasse; Alan E Fryer; Tim Cundy; William M Drake; Melita D Irving
Journal:  Orphanet J Rare Dis       Date:  2018-04-04       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.